Why the study?
Does TP-9201 prevent carotid artery rethrombosis after successful arterial thrombolysis in a canine model?
Does TP-9201 prevent carotid artery rethrombosis after successful arterial thrombolysis in a canine model?
In a canine model, the glycoprotein IIb/IIIa receptor antagonist TP-9201 successfully prevented rethrombosis after arterial thrombolysis.
No takes yet. Share an insight, caveat, or question.
Supports testing TP-9201 to sustain patency after thrombolysis; leaves open translation from canine models to patients.
Rebello et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: